Alprostadil vs. isosorbide dinitrate in ameliorating angina episodes in patients with coronary slow flow phenomenon: A randomized controlled trial

BACKGROUND: The optimum therapy for coronary slow flow phenomenon (CSFP) stays debatable. This study compared the effectiveness of alprostadil with isosorbide dinitrate in alleviating angina episodes in CSFP patients. METHODS: In this prospective, randomized controlled study, 102 patients with CSFP...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weifeng, Dai, Jinjie, Shen, Lan, Jiang, Yue, Zheng, Xiaowen, Xu, Ke, Yang, Xiaoxiao, Wang, Xiaolei, Hao, Ziyong, Zhao, Yu, Wang, Dong, Jiang, Lisheng, Qiu, Xingbiao, Shen, Linghong, He, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493040/
https://www.ncbi.nlm.nih.gov/pubmed/36158840
http://dx.doi.org/10.3389/fcvm.2022.965364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493040/
https://www.ncbi.nlm.nih.gov/pubmed/36158840
http://dx.doi.org/10.3389/fcvm.2022.965364

Ejemplares similares